Skip to content
10-Q

Quarterly Report

CalciMedica, Inc. CALC

0001193125-26-219426

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 7, 2026 15.8M sh
Shares Diluted Q1 2026 · Mar 31, 2026 16.33M sh
Shares Diluted Q1 2026 · Mar 31, 2025 14.12M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $9K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$4.86M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$4.88M
Short Term Investments Q1 2026 · Mar 31, 2026 $0
Short Term Investments Q1 2026 · Dec 31, 2025 $1.5M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $8.16M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $11.52M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$1.1M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$6.64M
Stockholders Equity Q1 2026 · Mar 31, 2025 $10.89M
Stockholders Equity Q1 2026 · Dec 31, 2024 $14.41M
Current Liabilities Q1 2026 · Mar 31, 2026 $5.31M
Current Liabilities Q1 2026 · Dec 31, 2025 $3.78M
Total Liabilities Q1 2026 · Mar 31, 2026 $9.71M
Total Liabilities Q1 2026 · Dec 31, 2025 $20.23M
Current Assets Q1 2026 · Mar 31, 2026 $8.56M
Current Assets Q1 2026 · Dec 31, 2025 $13.53M
Total Assets Q1 2026 · Mar 31, 2026 $8.61M
Total Assets Q1 2026 · Dec 31, 2025 $13.59M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.30
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.36
Eps Basic Q1 2026 · Mar 31, 2026 $0.31
Eps Basic Q1 2026 · Mar 31, 2025 −$0.36
Sga Expense Q1 2026 · Mar 31, 2026 $2.13M
Sga Expense Q1 2026 · Mar 31, 2025 $2.27M
Rd Expense Q1 2026 · Mar 31, 2026 $3.49M
Rd Expense Q1 2026 · Mar 31, 2025 $4.22M
Net Income Q1 2026 · Mar 31, 2026 $4.98M
Net Income Q1 2026 · Mar 31, 2025 −$5.04M
Operating Income Q1 2026 · Mar 31, 2026 −$5.61M
Operating Income Q1 2026 · Mar 31, 2025 −$6.5M